8 Best Quality Stocks to Buy According to Hedge Funds
On April 9, Tom Lee of Fundstrat appeared on CNBC's 'Closing Bell' to suggest that the market has reached a bottom.
Illumina Inc. (ILMN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 79,632 | $9,815,441 | -44% | 1.7% |
| 2. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $117.81 | 200 | $23,562.00 | 12,723 | 2026-02-09 | Filing | |
| $122.13 | 500 | $61,065.00 | 12,523 | 2025-11-03 | Filing | |
| $81.21 | 6,100 | $495,381.00 | 24,906 | 2025-05-12 | Filing | |
| $82.26 | 100 | $8,226.00 | 83,390 | 2025-05-13 | Filing | |
| $81.56 | 804 | $65,574.24 | 83,290 | 2025-05-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $116.18 | 1,336 | $155,216.48 | 16,334 | 2026-02-20 | Filing | |
| $116.18 | 2,370 | $275,346.60 | 16,321 | 2026-02-18 | Filing | |
| $136.09 | 323 | $43,957.07 | 17,887 | 2025-12-12 | Filing | |
| $129.27 | 549 | $70,969.23 | 10,952 | 2025-12-08 | Filing | |
| $112.84 | 315 | $35,544.60 | 8,314 | 2023-11-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 863,721 | $106,462,251 | 1.07% | |
| 2. | 327,174 | $40,327,488 | 0.58% | |
| 3. | 234,114 | $28,856,892 | 0.2% | |
| 4. | 113,057 | $13,444,504 | 0.03% | |
| 5. | 48,961 | $6,034,933 | 0.07% |
News See All
Illumina (ILMN) Gaining from Stronger Than Expected Results
Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Welcome to the Fourth Quarter 2025 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.
Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside
TheFly reported on January 7 that TD Cowen raised its price target on ILMN to $140 from $115 while maintaining a Hold rating.
Top 10 Oncology Stocks to Buy Now
The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by 2034 with a compound annual growth rate of 11.75%.
Illumina (ILMN) Soars 23.4% on Earnings Beat
“Illumina team delivered Q325 results that exceeded the high-end of our guidance range for revenue and earnings, driven by revenue acceleration in clinical, our largest market segment,” said CEO Jacob...
Illumina (ILMN) Jumps 24.8% on Earnings Beat
Illumina rallied for a second day on Friday, climbing 24.78 percent to close at $123.54 apiece after beating its earnings guidance in the third quarter of the year and projecting a lower revenue decline...
Illumina, Inc. (NASDAQ:ILMN) Q3 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Welcome to the Third Quarter 2025 Illumina Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Illumina (ILMN) Expands TruSight Oncology Test With New KRAS CDx Collaborations
Illumina Inc. (NASDAQ:ILMN) ranks among the top NASDAQ stocks with low P/E ratios. On September 23, Illumina Inc.
Top 9 NASDAQ Stocks with Low P/E Ratios
The August reading of the Personal Consumption Expenditures (PCE) index, which includes the Fed's preferred "core" PCE measure of inflation, found prices increasing as expected.